• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用营养补充剂提高氟西汀治疗神经性厌食症的疗效。

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.

作者信息

Barbarich Nicole C, McConaha Claire W, Halmi Katherine A, Gendall Kelly, Sunday Suzanne R, Gaskill Jill, La Via Maria, Frank Guido K, Brooks Sarah, Plotnicov Katherine H, Kaye Walter H

机构信息

Department of Psychiatry, University of Pittsburgh Medical School, Anorexia and Bulimia Nervosa Research Module, Pittsburgh, Pennsylvania 15213, USA.

出版信息

Int J Eat Disord. 2004 Jan;35(1):10-5. doi: 10.1002/eat.10235.

DOI:10.1002/eat.10235
PMID:14705152
Abstract

OBJECTIVE

Selective serotonin reuptake inhibitor (SSRI) medication does not appear to be effective in ill, malnourished anorexia nervosa (AN) patients. However, it may be effective in preventing relapse after weight restoration. The purpose of this study was to determine whether nutritional supplements could potentiate the effects of fluoxetine in underweight AN subjects.

METHOD

Twenty-six subjects with AN participated in a trial of fluoxetine. In a double-blind, placebo-controlled manner, subjects received either nutritional supplements or a nutritional placebo. The nutritional supplement included tryptophan (the precursor of serotonin), vitamins, minerals, and essential fatty acids believed to influence serotonin pathway function.

RESULTS

There was no significant difference in weight gain between subjects treated with fluoxetine plus nutritional supplements versus fluoxetine plus a nutritional placebo. Moreover, there were no significant differences between groups on mean changes in anxiety or obsessive and compulsive symptoms.

DISCUSSION

The results of this study suggest that supplement strategies are not a substitute for adequate nutrition and are ineffective in increasing the efficacy of fluoxetine in underweight AN subjects.

摘要

目的

选择性5-羟色胺再摄取抑制剂(SSRI)药物对患病且营养不良的神经性厌食症(AN)患者似乎无效。然而,它可能对体重恢复后的复发预防有效。本研究的目的是确定营养补充剂是否能增强氟西汀对体重过轻的AN患者的疗效。

方法

26名AN患者参与了氟西汀试验。以双盲、安慰剂对照的方式,受试者接受营养补充剂或营养安慰剂。营养补充剂包括色氨酸(5-羟色胺的前体)、维生素、矿物质以及据信会影响5-羟色胺途径功能的必需脂肪酸。

结果

接受氟西汀加营养补充剂治疗的受试者与接受氟西汀加营养安慰剂治疗的受试者在体重增加方面无显著差异。此外,两组在焦虑或强迫症状的平均变化上也无显著差异。

讨论

本研究结果表明,补充策略不能替代充足的营养,且对提高氟西汀对体重过轻的AN患者的疗效无效。

相似文献

1
Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.使用营养补充剂提高氟西汀治疗神经性厌食症的疗效。
Int J Eat Disord. 2004 Jan;35(1):10-5. doi: 10.1002/eat.10235.
2
Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.氟西汀在限制型及限制-清除型神经性厌食症中的双盲安慰剂对照给药。
Biol Psychiatry. 2001 Apr 1;49(7):644-52. doi: 10.1016/s0006-3223(00)01013-1.
3
Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.氟西汀用于神经性厌食症体重恢复后:一项随机对照试验。
JAMA. 2006 Jun 14;295(22):2605-12. doi: 10.1001/jama.295.22.2605.
4
Use of fluoxetine in anorexia nervosa before and after weight restoration.厌食症体重恢复前后使用氟西汀。
Ann Pharmacother. 2013 Sep;47(9):1201-5. doi: 10.1177/1060028013503127.
5
Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.奥氮平与氟西汀治疗神经性厌食症同卵双胞胎的体重恢复差异。
Int J Eat Disord. 2012 Mar;45(2):294-7. doi: 10.1002/eat.20917. Epub 2011 Feb 22.
6
Does fluoxetine augment the inpatient treatment of anorexia nervosa?氟西汀能否增强神经性厌食症的住院治疗效果?
Am J Psychiatry. 1998 Apr;155(4):548-51. doi: 10.1176/ajp.155.4.548.
7
Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?5-羟色胺选择性再摄取抑制剂对体重过轻的神经性厌食症有效吗?
Int J Eat Disord. 1999 Jan;25(1):11-7. doi: 10.1002/(sici)1098-108x(199901)25:1<11::aid-eat2>3.0.co;2-u.
8
Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.厌食症和贪食症中血清素神经元功能及选择性血清素再摄取抑制剂治疗
Biol Psychiatry. 1998 Nov 1;44(9):825-38. doi: 10.1016/s0006-3223(98)00195-4.
9
An open trial of fluoxetine in patients with anorexia nervosa.氟西汀治疗神经性厌食症患者的开放性试验。
J Clin Psychiatry. 1991 Nov;52(11):464-71.
10
Obsessive-compulsive disorder, trichotillomania, and anorexia nervosa: a case report.强迫症、拔毛癖和神经性厌食症:一例报告
Int J Eat Disord. 1995 Dec;18(4):375-9. doi: 10.1002/1098-108x(199512)18:4<375::aid-eat2260180412>3.0.co;2-s.

引用本文的文献

1
Weight Stigma in Medicine.医学中的体重歧视
Focus (Am Psychiatr Publ). 2025 Jan;23(1):49-52. doi: 10.1176/appi.focus.20240031. Epub 2025 Jan 15.
2
Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case-control study.非典型抗精神病药物的使用对患有极端神经性厌食症的个体的体重增加没有影响:一项回顾性病例对照研究。
J Eat Disord. 2023 Dec 6;11(1):215. doi: 10.1186/s40337-023-00941-6.
3
Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review.
饮食失调的药物治疗、替代疗法和辅助疗法:快速综述的结果
J Eat Disord. 2023 Jul 6;11(1):112. doi: 10.1186/s40337-023-00833-9.
4
New Perspective on Anorexia Nervosa: Tryptophan-Kynurenine Pathway Hypothesis.神经性厌食症的新视角:色氨酸-犬尿氨酸途径假说。
Nutrients. 2023 Feb 18;15(4):1030. doi: 10.3390/nu15041030.
5
Psychopharmacologic Management of Eating Disorders.精神药理学与进食障碍的治疗
Curr Psychiatry Rep. 2022 Jul;24(7):345-351. doi: 10.1007/s11920-022-01340-5. Epub 2022 May 16.
6
No effects of acute tryptophan depletion on anxiety or mood in weight-recovered female patients with anorexia nervosa.急性色氨酸耗竭对神经性厌食症体重恢复女性患者的焦虑或情绪无影响。
Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):209-217. doi: 10.1007/s00406-022-01414-8. Epub 2022 May 5.
7
Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?治疗神经性厌食症的药物治疗策略——一种药物是否太多?
Expert Opin Pharmacother. 2020 Jun;21(9):1045-1058. doi: 10.1080/14656566.2020.1748600. Epub 2020 Apr 13.
8
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?多不饱和脂肪酸:它们在治疗精神疾病方面的作用是什么?
Int J Mol Sci. 2019 Oct 23;20(21):5257. doi: 10.3390/ijms20215257.
9
Alterations in serotonin transporter and body image-related cognition in anorexia nervosa.厌食症中 5-羟色胺转运体和与身体意象相关认知的改变。
Neuroimage Clin. 2019;23:101928. doi: 10.1016/j.nicl.2019.101928. Epub 2019 Jul 3.
10
The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders.ω-3脂肪酸在神经精神疾病治疗中的新兴作用。
Ther Adv Psychopharmacol. 2019 Jun 24;9:2045125319858901. doi: 10.1177/2045125319858901. eCollection 2019.